Clinical OMICS

NOV-DEC 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 17 of 51

Wikimedia Commons 16 Clinical OMICs November/December 2018 B olstered by $200 million from equity firm General Atlantic, and with the par- ticipation of three founding oncology practices, OneOncology launched in mid-September organized around technology and economies of scale to help community cancer centers operate more effectively across the continuum of care in preparation for the challenges of new value-based reimbursement models. "The rapid pace of innovation, from drug regimens and technology to changes in reimbursement and changes in regulations, have put pressure on community oncolo- gists and they have struggled to respond," said Tracy Bahl, OneOncology CEO. "Many have sold to hospitals as a way to deal with these pressures. Others have tried to tough it out, but not always successfully. We think OneOncology brings an alternative that allows them to focus on the treatment of patients with cancer and allows a partner like OneOncolgy to manage the operational and administrative parts of their practices." At launch, the company announced its first three member practices: Tennessee Oncol- ogy, New York Cancer & Blood Specialists, and West Cancer Center, which in total rep- Chris Anderson Editor in Chief OneOncology Launches with Plans to Build a National Network of Community Oncology Centers Community Care Julie Flanery (West Cancer Center)

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - NOV-DEC 2018